Recruiting studies: Malabsorption Syndromes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-ce
Phase N/A · 1 location(s) · Hospital Mutua de Terrassa · NCT07070596 Development of New Diagnostic Tools in Capsule Endoscopy
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152289 Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac
NA · 1 location(s) · University Health Network, Toronto · NCT07636382 A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NA · 2 location(s) · Boston Children's Hospital · NCT03530852 Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Phase 2 · 14 location(s) · Hanmi Pharmaceutical Company Limited · NCT04775706 Bile Acids and Microbiome in Early Colorectal Carcinogenesis
Phase N/A · 1 location(s) · Vilnius University · NCT06502704 Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Phase 2 · 1 location(s) · University of Washington · NCT05340465 Milk for Diabetes Prevention
NA · 1 location(s) · Albert Einstein College of Medicine · NCT06513026 Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
Phase 2 · 1 location(s) · Dr. Falk Pharma GmbH · NCT07298343 Gfree - For Improved Blood Sugar and Reduced Inflammation.
NA · 2 location(s) · Göteborg University · NCT05894746 General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Phase N/A · 4 location(s) · Sanford Health · NCT04477928 Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction
NA · 1 location(s) · Romanian Society for Enteral and Parenteral Nutrition · NCT06510348 Fiber Food Introduction in Pediatric Short Bowel Syndrome
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT05432648 Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Phase 3 · 23 location(s) · Zealand Pharma · NCT07197944 Urine Metabolites in the Diagnosis of Disease
Phase N/A · 4 location(s) · Luventix, Inc. · NCT06710067 Probiotic in Patients With Bile Acid Malabsorption/Diarrhea
NA · 1 location(s) · Mayo Clinic · NCT06609148 Gluten Technology and Education for Celiac Health
NA · 4 location(s) · Columbia University · NCT06059716 Liver Steatosis in Pediatric CD Patients
Phase N/A · 2 location(s) · University of Palermo · NCT06206616 Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
Phase 2 · 1 location(s) · Elgan Pharma Ltd. · NCT05904626 Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
Phase N/A · 2 location(s) · Massachusetts General Hospital · NCT02061306 A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Phase 3 · 4 location(s) · Takeda · NCT06973304 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620 Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
Phase 4 · 2 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07691125 Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510 Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Phase N/A · 14 location(s) · Boston Children's Hospital · NCT04629014 Tryptophan for Impaired AhR Signaling in Celiac Disease
NA · 1 location(s) · McMaster University · NCT05576038 NCWS or IBS/FD in Relatives of CD Patients
NA · 2 location(s) · University of Palermo · NCT07584473 Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Co
Phase 2 · 8 location(s) · Napo Therapeutics, S.p.A. · NCT06904872 Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
Phase 2 · 1 location(s) · Forte Biosciences, Inc. · NCT06982963 AI System for Detection and Characterization of Chronic Enteropathies
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07387185

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.